Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Assets Average (2016 - 2025)

Cytosorbents (CTSO) has disclosed Assets Average for 13 consecutive years, with $46.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Assets Average fell 7.4% year-over-year to $46.9 million, compared with a TTM value of $46.9 million through Sep 2025, down 7.4%, and an annual FY2024 reading of $50.3 million, down 13.61% over the prior year.
  • Assets Average was $46.9 million for Q3 2025 at Cytosorbents, down from $47.6 million in the prior quarter.
  • Across five years, Assets Average topped out at $96.6 million in Q3 2021 and bottomed at $46.9 million in Q3 2025.
  • Average Assets Average over 5 years is $66.2 million, with a median of $60.3 million recorded in 2023.
  • The sharpest move saw Assets Average soared 147.78% in 2021, then crashed 32.01% in 2022.
  • Year by year, Assets Average stood at $92.3 million in 2021, then tumbled by 32.01% to $62.8 million in 2022, then dropped by 19.65% to $50.4 million in 2023, then dropped by 5.61% to $47.6 million in 2024, then dropped by 1.51% to $46.9 million in 2025.
  • Business Quant data shows Assets Average for CTSO at $46.9 million in Q3 2025, $47.6 million in Q4 2024, and $50.6 million in Q3 2024.